Composition
- Active ingredients
- ROPINIROLE HYDROCHLORIDE EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ROPINIROLE HYDROCHLORIDE EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA022008-005 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseThis page
- ROPINIROLE HYDROCHLORIDE EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA022008-001 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA022008-006 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA022008-004 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA022008-002 · Discontinued
Official product information
At a glance
- Brand name
- Requip XL
- Active substance
- ropinirole hydrochloride
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Glaxosmithkline LLC
- Status
- Discontinued
- FDA approval
- 13 Jun 2008
- Application
- NDA022008-003